Virax Biolabs Group annual operating income
2021
2022
2023
2024
2025
2026
Virax Biolabs Group Operating Income Growth & History (VRAX)
Virax Biolabs Group's operating income was −$6.4M for fiscal 2026.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$6.4M | −$236,833 | — |
| 2025 | 2025-03-31 | −$6.2M | $333,576 | — |
| 2024 | 2024-03-31 | −$6.5M | −$763,712 | — |
| 2023 | 2023-03-31 | −$5.7M | −$4.0M | — |
| 2022 | 2022-03-31 | −$1.7M | −$1.1M | — |
| 2021 | 2021-03-31 | −$644,538 | — | — |
Virax Biolabs Group operating income trends
Over the last five fiscal years, Virax Biolabs Group's operating income decreased from −$644,538 to −$6.4M, a change of −$5.8M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group source filings ↗